Subscribe to Newsletter

Search

Reset Filter

4107 search results for ‘*’

Business & Regulation Standards & Regulation

EFPIA Calls For Clarity Over JCA Concerns

| Rob Coker | 2 min read

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.


Business & Regulation Digital Technologies

The Rise of Digital Health

| 2 min read

From wearable health tech to telehealth, here’s how digital transformation could impact the pharma industry and patient access.


Manufacture Technology and Equipment

Pairing Genomic Medicine with AI

| 3 min read

A partnership between WhiteLab Genomics and Debiopharm will seek to use AI to streamline the development of targeted cancer therapies.


Business & Regulation Business Practice

Proactive Pharmacovigilance is the Game Changer Biotech Needs

| Laura Hopper | 3 min read

Why a forward-thinking approach is crucial for patient safety and industry success

Manufacture Small Molecules

Small World

| Rob Coker | 5 min read

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

Business & Regulation Digital Technologies

AI and the Copyright Question for R&D

| Rob Coker | 2 min read

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.

Discovery & Development Drug Delivery

Drug Delivery Growth Spurt

How next-generation drug delivery and advanced automation are set to transform pharma’s future.

Business & Regulation Trends & Forecasts

Smart and Sustainable: Pharma’s Future

| 3 min read

How will digitalization and automation redefine pharma manufacturing in the next decade?

Manufacture Technology and Equipment

The Benefits of AI and Automation in the Lab

| 3 min read

Welcome to the labs of the future, with increased efficiency with robotics and automation, and new insights powered by AI and machine learning.

Discovery & Development Drug Discovery

Takeda’s Chinwe Ukomadu and Chris Arendt on Biopharma’s Future

| 3 min read

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register